At closing price yielding 6.4% with probable final div increasing as well. Although good to have major clients the Astra zeneca loss may not be so bad if replaced by a few smaller customers.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report
At closing price yielding 6.4% with probable final div...
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit